Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca's Scientific Advisory Board
SÖDERTÄLJE, Sweden, April 7, 2022 /PRNewswire/ -- Anocca, a biotechnology company using its precision biology platforms to engineer a broad portfolio of innovative T cell therapeutics, today
Source: finanznachrichten.de